# Nocardia Rubra Cell Wall Skeleton in Combination With Prior Second- or Third-line Regimens for the Treatment of Potentially Hazardous Colorectal Cancer SD Status

> **NCT06356714** · PHASE2 · RECRUITING · sponsor: **Sun Jing** · enrollment: 22 (estimated)

## Conditions studied

- Colorectal Cancer
- Colorectal Neoplasms

## Interventions

- **DRUG:** Nocardia Rubra Cell Wall Skeleton in Combination With Prior Second- or Third-line Regimens

## Key facts

- **NCT ID:** NCT06356714
- **Lead sponsor:** Sun Jing
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03-15
- **Primary completion:** 2026-09-24
- **Final completion:** 2027-10-01
- **Target enrollment:** 22 (ESTIMATED)
- **Last updated:** 2025-08-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06356714

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06356714, "Nocardia Rubra Cell Wall Skeleton in Combination With Prior Second- or Third-line Regimens for the Treatment of Potentially Hazardous Colorectal Cancer SD Status". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT06356714. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*